TABLE 2.
Univariate and multivariate analyses of prognostic variables for overall survival.
| Characteristics | Total(N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | p Value | Hazard ratio (95% CI) | p Value | ||
| T stage (T3-4 vs T1-2) | 523 | 2.317 (1.591–3.375) | <0.001*** | 1.652 (1.020–2.673) | 0.041* |
| N stage (N2-3 vs N0-1) | 510 | 2.321 (1.631–3.303) | <0.001*** | 1.476 (0.725–3.003) | 0.283 |
| M stage (M1 vs M0) | 377 | 2.136 (1.248–3.653) | 0.006** | 1.158 (0.531–2.526) | 0.712 |
| Pathologic stage (Stage III- IV vs Stage I- II) | 518 | 2.664 (1.960–3.621) | <0.001*** | 1.651 (0.771–3.534) | 0.197 |
| Gender (Male vs Female) | 526 | 1.070 (0.803–1.426) | 0.642 | — | — |
| Age (>65 vs ≤65) | 516 | 1.223 (0.916–1.635) | 0.172 | — | — |
| Smoker (Yes vs No) | 512 | 0.894 (0.592–1.348) | 0.591 | — | — |
| ALDOA (High vs Low) | 526 | 1.799 (1.342–2.413) | <0.001*** | 1.435 (1.013–2.032) | 0.042* |
p < 0.05; p < 0.01; p < 0.001.